VITAMİN D MUCİZESİ- MIRACLE OF VITAMIN D

   

D3 (CHOLECALCIFEROL): SIVI VITAMIN D3 (CHOLECALCIFEROL) GÜNDE 10000 IU ALIMI.  VİTAMİN D SİNİR KILIFLARINA ZARAR VEREN BAĞIŞIKLIK SİSTEMİ HÜCRELERİNE MANİ OLURKEN DİĞER TARAFTAN KORUYUCU BAĞIŞIKLIK SİSTEMİ HÜCRELERİNİ (T DÜZENLEYİCİ HÜCRELER) GÜÇLENDİRİR.

VİTAMİN D, ANTİBAKTERİEL PEPTİLERİ DE GÜÇLENDİRİR.

SARKODİOZ, AĞIR BÖBREK RAHATSIZLIĞI, HİPERPARATROİD VE KANDA YÜKSEK KALSİYUM SEVİYESİ OLAN HASTALAR DOKTORLARINA DANIŞMADAN D VİTAMİNİ ALMAMALIDIR.

AŞIRI SENTETİK A VİTAMİNİ D VİTAMİNİ EMİLİMİNİ ENGELLER. 500-1000 IU A VİTAMİNE KARŞI 2000-3000 VİTAMİN D ALINMALIDIR. VİTAMİN A’NIN BETA KAROTEN OLARAK ALIMI D VİTAMİNİ EMİLİMİNİ ETKİLEMEZ. BETA KAROTEN BÜNYENİN İHTİYACINA GÖRE VÜCUTTA A VİTAMİNİNE DÖNÜŞÜR.

KANDA 1.000 IU DAN 2.300’E KADAR SENTETİK A VİTAMİNİ GÖRÜLMESİ ÜZERİNE  TAM KAN SAYIMI VE 25-HYDROXYVİTAMİN D TESTİ YAPTIRILMALIDIR. BÖYLECE KANDA KALSİYUM VE BÖBREK FONKSİYONLARININ NORMAL DEĞERLERDE OLDUĞU KONTROL EDİLMELİDİR.

KİLOLU KİMSELER ZAYIF KİMSELERE GÖRE DAHA FAZLA VİTAMİN D İHTİYACI DUYARLAR.

VİTAMİN D HÜCRE ÇEVRİMİNDE GENETİK DÜZENLEYİCİLERİ OLUMLU YÖNDE ETKİLEMEKTEDİR. (BEN-SHOSHAN 2007; LEE 2007; JAMSHIDI 2008; CREW 2009)

VITAMIN D MUTASYONA UĞRAMIŞ HÜCRELERİN HABİS HÜCRELERE DÖNÜŞMESİNİ ENGELLER VE DAHASI KANSER HÜCRELERİNİN ÖLÜMÜNÜ ARTTIRIR. ARAŞTIRMALAR GÜNDE 1100 IU VİTAMİN D VE YETERLİ KALSİYUM ALIMININ KANSER RİSKİNİ %60 AZALTTIĞINI GÖSTERMEKTEDİR (LAPPE 2007).

VUCUTTA VİTAMİN D SENTEZİ GÜNEŞ IŞIĞINA BAĞLIDIR.

A LIQUID VITAMIN D SUPPLEMENT THAT HAS 5000 IU PER SERVING IS BEST, SINCE LIQUID IS FAST ABSORBING. OR MS PATIENTS GIVEN 28,000- 280,000 IU WEEKLY WERE FOUND TO HAVE FEWER ACTIVE LESIONS DURING THE 28 WEEK LONG STUDY (KIMBALL, 2007).

VITAMIN D SYNTHESIS DEPENDS UPON EXPOSURE OF THE SKIN TO SUNLIGHT; THE SUMMER MONTHS ALSO BRING THE HIGHEST BLOOD LEVELS OF VITAMIN D (TREMLETT 2008). A RECENT STUDY HAS QUANTIFIED THE IMPACT OF VITAMIN D BLOOD LEVELS ON RISK FOR MS RELAPSE – FOR EACH 4 NG/ML INCREASE IN 25-HYDROXY VITAMIN D IN THE BLOOD, THE RISK FOR MS RELAPSE IS REDUCED BY 12%. THE INVESTIGATORS WHO CONDUCTED THIS STUDY CONCLUDED THAT “CLINICALLY, RAISING 25-HYDROXY VITAMIN D LEVELS BY [20 NG/ML] COULD HALVE THE HAZARD OF A RELAPSE” (SIMPSON 2010).

HOWEVER, VITAMIN D DOES MORE THAN JUST ARREST DAMAGING IMMUNE CELLS; IT ALSO SUPERCHARGES PROTECTIVEIMMUNE CELLS.

T-REG CELLS ARE SPECIALIZED COMPONENTS OF THE IMMUNE SYSTEM THAT HELP KEEP IMMUNITY BALANCED. IF TOO FEW T-REG CELLS ARE PRESENT, THE IMMUNE SYSTEM BECOMES OVERACTIVE, AS IN AUTOIMMUNE DISEASES LIKE MS. VITAMIN D INCREASES THE NUMBER OF PROTECTIVE T-REG CELLS, RESTORING EQUILIBRIUM TO AN OVERACTIVE IMMUNE SYSTEM (CORREALE 2009).

VITAMIN D DRAMATICALLY UPREGULATES THE EXPRESSION OF THE ANTIMICROBIAL PEPTIDES

ADULTS NEED TO TAKE 5,000-10.000  IU A DAY OF VITAMIN D TO PUT THE VAST MAJORITY OF THEM (97.5%)  ABOVE THE 50 NG/ML LEVEL. THE STANDARD LABORATORY REFERENCE RANGE FOR 25-HYDROXYVITAMIN D WAS RAISED TO 32-100 NG/ML. INITIALLY RECOMMENDED A MINIMUM TARGET BLOOD LEVEL OF 30 NG/ML OF 25-HYDROXYVITAMIN D.

IN A RANDOMIZED CONTROLLED TRIAL, SUPPLEMENTATION WITH DOSES OF VITAMIN D RANGING FROM 10,000 IU TO 40,000 IU DAILY OVER THE COURSE OF 52 WEEKS RESULTED IN A REDUCTION IN RELAPSES AND A REDUCTION IN THE NUMBER OF AGGRESSIVE IMMUNE CELLS IN PATIENTS WITH MS (BURTON 2010).

MAINTAIN A BLOOD LEVEL OF 50 – 80 NG/ML. IT MEANS THAT A SUPPLEMENTATION OF 5,000- 8,000 IU OF VITAMIN D EACH DAY IS SUFFICIENT TO REACH THESE LEVELS.

THOSE WITH A RARE DISORDER CALLED SARCOIDOSIS, SEVERE RENAL IMPAIRMENT, PRIMARY HYPERPARATHYROIDISM, OR ANY CONDITION RESULTING IN AN ELEVATED CALCIUM LEVEL IN THE BLOOD SHOULD CONSULT WITH THEIR PHYSICIAN BEFORE TAKING VITAMIN D SUPPLEMENTS.

EXCESS PREFORMED VITAMIN A (NOT THE BETA CAROTEN) CAN COMPETE AND THWART VITAMIN D. APPROPRIATE DOSE IS 500-1,000 IU OF VITAMIN A AND 2,000-3,000 IU OF VITAMIN D. BETA-CAROTENE, AS IT CONVERTS TO VITAMIN A IN THE BODY ONLY ON DEMAND.

TO AVOID EXCESS LEVELS OF PREFORMED VITAMIN A (GREATER THAN 1,000 IU TO 2,300 IU). HAVE A BLOOD TEST (CBC/CHEMISTRY AND 25-HYDROXYVITAMIN D) WITHIN THE NEXT TWO MONTHS TO EVALUATE YOUR VITAMIN D STATUS AND TO MAKE SURE YOUR BLOOD CALCIUM AND KIDNEY FUNCTION INDICATORS ARE IN NORMAL RANGES.

HEAVIER PEOPLE REQUIRE MORE VITAMIN D THAN THINNER INDIVIDUALS.

VITAMIN D IS FAVORABLY ALTERING GENETIC REGULATORS OF THE CELL CYCLE (BEN-SHOSHAN 2007; LEE 2007; JAMSHIDI 2008; CREW 2009)

VITAMIN D HELPS PREVENT MUTATED CELLS FROM BECOMING MALIGNANT AND EVEN INDUCES CANCER CELL DEATH (APOPTOSIS). HUMAN STUDIES SHOW THAT DOSES OF 1100 IU VITAMIN D DAILY PLUS CALCIUM RESULT IN A 60% RISK REDUCTION FOR DEVELOPING ANY CANCER, COMPARED WITH PLACEBO (LAPPE 2007).

Bir Cevap Yazın

Please log in using one of these methods to post your comment:

WordPress.com Logosu

WordPress.com hesabınızı kullanarak yorum yapıyorsunuz. Çıkış  Yap /  Değiştir )

Google+ fotoğrafı

Google+ hesabınızı kullanarak yorum yapıyorsunuz. Çıkış  Yap /  Değiştir )

Twitter resmi

Twitter hesabınızı kullanarak yorum yapıyorsunuz. Çıkış  Yap /  Değiştir )

Facebook fotoğrafı

Facebook hesabınızı kullanarak yorum yapıyorsunuz. Çıkış  Yap /  Değiştir )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.